Smallpox was one of the most dangerous and highly contagious diseases that the world has ever known. Prior to its eradication, the illness claimed over one billion lives. Vaccination has played a major role in finally ridding the human race of smallpox. However, scientists recently proved that it can be revived quite easily and for a relatively small amount of only $100,000.
As financial matters go, $100,000 might not seem cheap, but it’s a pittance compared to the funding that governments and private organizations funnel into their scientific research. What’s more, radical groups and terrorist chapters are known for having deep pockets. Weaponized smallpox would be a devastating weapon and Canadian scientists recently proved that it can be done, The Verge reports.
To be clear, the organism that the research group led by virologist David Evans revived was not smallpox, but its cousin horsepox. With a limited budget to work with and garden variety tools, the team managed to resurrect a rather harmless piece of history.
As far as scientific pursuits go, this development is a wonder. For researchers to make such an achievement with no considerable funding or specialized equipment is simply masterful.
On the other hand, it also puts the world in grave danger. As Science magazine put it, getting rid of smallpox took decades of effort and billions of dollars in funding, not to mention the lives lost in the process. The idea that individuals with nefarious purposes can undo so much work with nothing more than what amounts to the costs of a luxury car and order supplies online is alarming, to say the least.
For Dr. Evans and his team, what they were hoping to achieve is to unlock the secrets of the smallpox vaccine and create a better, more powerful one. Unfortunately, good intentions have never prevented those with evil schemes from using scientific advances to further their own ends.


FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 



